Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06377878 · ClinicalTrials.gov registry record
The Preeclampsia Registry
A clinical trial of Preeclampsia and Hypertensive Disorder of Pregnancy, sponsored by Preeclampsia Foundation.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT06377878 is a study of Preeclampsia and Hypertensive Disorder of Pregnancy that is actively recruiting participants, run by Preeclampsia Foundation. The registered enrollment target is 20,000 participants, above the 769-participant average among 39 other Preeclampsia trials with a reported enrollment target (2501% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06377878, a study of Preeclampsia and Hypertensive Disorder of Pregnancy, is actively recruiting participants, sponsored by Preeclampsia Foundation.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medical research to try to understand why preeclampsia occurs, how to predict it better, and to develop experimental clinical trials of new treatments. The Registry will consist of a web-based survey and mechanism for collecting and reviewing medical records. This data will be utilized for immediate investigator-driven cross-sectional research projects (after proposal review by the Registry's scientific advisory board and as directed by the PI). Participants may also choose to be contacted regarding possible participation in future studies, about providing a biospecimen, as well as investigator-driven clinical trials. The Registry is anticipated to exist long-term and to serve as a foundation of participants from which to draw for studies of preeclampsia, anticipated to evolve as our scientific understanding of preeclampsia evolves.
Conditions Studied
Study Locations (1)
Florida
- Preeclampsia Foundation - Melbourne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2013-09-01 |
| Est. Completion | 2040-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06377878
The ClinicalTrials.gov registry entry for NCT06377878 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 769-participant average among 39 other Preeclampsia trials with a reported enrollment target (2501% higher). The listed sponsor is Preeclampsia Foundation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT06377878 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06377878 about?
NCT06377878 is a clinical study titled "The Preeclampsia Registry". The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who...
What is the current status of trial NCT06377878?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2013-09-01. Estimated completion is 2040-05.
What conditions does trial NCT06377878 study?
This clinical trial studies the following conditions: Preeclampsia, Hypertensive Disorder of Pregnancy, Toxemia, Eclampsia, HELLP Syndrome.
Who is sponsoring clinical trial NCT06377878?
This trial is sponsored by Preeclampsia Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06377878 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.